Hair Quiz | Locklab

Where are you noticing hair loss?

Along the hairline

At the crown

All over

My hair's fine. Just thinking ahead.

Already have an account? Sign In

What are you hoping for most from your treatment?

I want to prevent hair loss

I want to regrow my hair

I want thicker hair

Great! Locklab prevents hair loss for 97% of men.

Great! Locklab stimulates regrowth for 90% of men.

Great! Locklab thickens and preserves hair for 97% of men.

Before

Before

Month 5

Month 5

Before

Before

Month 4

Month 4

Before

Before

Month 12

Month 12

Are you currently experiencing any of the following?

Low blood pressure

Heart palpitations

No, none of these

Locklab contains 5mg of oral minoxidil that can’t be prescribed to patients with low blood pressure

Continue anyway

Have you tried other hair loss treatments before?

Yes

No

Why are you making the switch?

Select all that apply

Topicals weren’t effective / comfortable

I want the benefits of a 3-in-1

I’m trying something new

You’re in the right place

Locklab is 35% more effective than generic treatments, and 60% more effective than topicals.

Reviewing your answers...

Great news—you’re eligible for treatment.

You’re in the right place

Locklab is 35% more effective than generic treatments, and 60% more effective than topicals.

Oops! Something went wrong while submitting the quiz. Please recheck your email!

Locklab vs. Others

More Effective Than Generics
Locklab’s combination of 5mg of minoxidil, 1.1mg of finasteride, & 1mg of biotin offers 35% higher efficacy than generic and solo treatments, and a faster response time.^{1a, 1b}

More Effective Than Topicals
60% of men don’t respond well to topical minoxidil due to a biological shortage of sulfotransferase, the enzyme that converts minoxidil into its active form. ²

Easier to Use
86.3% of men discontinue using topical treatments—one factor being the difficulty associated with consistent use.³

Sources

a) Panchaprateep, R., Lueangarun, S., “Efficacy of Oral Minoxidil 5mg in the Treatment of Male Patients with Androgenetic Alopecia” Dermatol Ther.  b) Beach, Renée A. et al. “A 3-year North American retrospective case series” J. of the American Academy of Dermatology.
Kaiser M. et al. “Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs” Clin Cosmet Investig Dermatol.
Shadi Z. “Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia” Dermatol Ther.